These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7447203

  • 1. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.
    Waxman HL, Myerburg RJ, Appel R, Sung RJ.
    Ann Intern Med; 1981 Jan; 94(1):1-6. PubMed ID: 7447203
    [Abstract] [Full Text] [Related]

  • 2. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
    Sung RJ, Waxman HL, Elser B, Juma Z.
    Clin Invest Med; 1980 Jan; 3(1-2):41-7. PubMed ID: 7009003
    [No Abstract] [Full Text] [Related]

  • 3. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ, Pfitzner P.
    Med Klin (Munich); 1996 Oct 15; 91(10):617-25. PubMed ID: 9019638
    [Abstract] [Full Text] [Related]

  • 4. Treatment of supraventricular arrhythmias with intravenous and oral verapamil.
    Gonzalez R, Scheinman MM.
    Chest; 1981 Oct 15; 80(4):465-70. PubMed ID: 7023864
    [Abstract] [Full Text] [Related]

  • 5. Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil.
    Tommaso C, McDonough T, Parker M, Talano JV.
    Arch Intern Med; 1983 May 15; 143(5):877-81. PubMed ID: 6679229
    [Abstract] [Full Text] [Related]

  • 6. The effect of magnesium versus verapamil on supraventricular arrhythmias.
    Gullestad L, Birkeland K, Mølstad P, Høyer MM, Vanberg P, Kjekshus J.
    Clin Cardiol; 1993 May 15; 16(5):429-34. PubMed ID: 8504578
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N, Penev A, Kaponov Kh.
    Vutr Boles; 1984 May 15; 23(1):63-9. PubMed ID: 6730453
    [Abstract] [Full Text] [Related]

  • 8. [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
    Piccini A, Malfatti S.
    Minerva Med; 1975 May 26; 66(39):1923-31. PubMed ID: 48221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
    Platia EV, Michelson EL, Porterfield JK, Das G.
    Am J Cardiol; 1989 Apr 15; 63(13):925-9. PubMed ID: 2564725
    [Abstract] [Full Text] [Related]

  • 11. Short-term control of supraventricular tachycardia with verapamil infusion and calcium pretreatment.
    Barnett JC, Touchon RC.
    Chest; 1990 May 15; 97(5):1106-9. PubMed ID: 2331904
    [Abstract] [Full Text] [Related]

  • 12. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G, Lefkos N, Efthymiadis AP, Styliadis IG, Tsapas G.
    Acta Cardiol; 1995 May 15; 50(2):125-34. PubMed ID: 7610735
    [Abstract] [Full Text] [Related]

  • 13. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG.
    Am J Cardiol; 1989 Mar 15; 63(11):693-6. PubMed ID: 2493733
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.
    Panidis IP, Morganroth J, Baessler C.
    Am J Cardiol; 1983 Dec 01; 52(10):1197-201. PubMed ID: 6359848
    [Abstract] [Full Text] [Related]

  • 15. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL.
    Pharmacotherapy; 1997 Dec 01; 17(6):1238-45. PubMed ID: 9399606
    [Abstract] [Full Text] [Related]

  • 16. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA.
    Am Heart J; 1995 Apr 01; 129(4):739-48. PubMed ID: 7900626
    [Abstract] [Full Text] [Related]

  • 17. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK, Singh BN, Roche AH, Norris RM, Mercer CJ.
    Am Heart J; 1975 Oct 01; 90(4):487-98. PubMed ID: 1163442
    [Abstract] [Full Text] [Related]

  • 18. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL, DaTorre SD, Platt ML, McCarville SE, Hougham AJ.
    J Am Coll Cardiol; 1991 Feb 01; 17(2):297-303. PubMed ID: 1899432
    [Abstract] [Full Text] [Related]

  • 19. Double-blind crossover randomized trial of intravenously administered verapamil. Its use for atrial fibrillation and flutter following open heart surgery.
    Hwang MH, Danoviz J, Pacold I, Rad N, Loeb HS, Gunnar RM.
    Arch Intern Med; 1984 Mar 01; 144(3):491-4. PubMed ID: 6703818
    [Abstract] [Full Text] [Related]

  • 20. [Antiarrhythmic effects of verapamil].
    Shapiro M, Malo R, Férez S, Martínez-Ríos MA, Salazar E.
    Arch Inst Cardiol Mex; 1976 Mar 01; 46(3):305-16. PubMed ID: 1088854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.